XML 58 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Debt - Long-Term Debt from Royalty-Bearing Instrument-December 2012 Financing - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 06, 2012
Nov. 30, 2020
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Debt Disclosure [Line Items]            
Long-term debt from royalty-bearing instrument, carrying amount net of unamortized discount     $ 9,387,000 $ 9,387,000   $ 49,702,000
Interest expense, non-cash       601,000 $ 1,282,000  
CPPIB            
Debt Disclosure [Line Items]            
Maximum repayment of future revenue and receivables     9,600,000 9,600,000    
Interest repayment on future revenue and receivables     100,000 100,000    
Repayment under agreement     13,400,000 $ 42,800,000    
CPPIB | Scenario Forecast            
Debt Disclosure [Line Items]            
Repayment under agreement   $ 9,600,000        
VASCEPA            
Debt Disclosure [Line Items]            
Debt and future repayments percentage of net product revenues       10.00%    
VASCEPA | CPPIB            
Debt Disclosure [Line Items]            
Debt and future repayments percentage of net product revenues       10.00%    
BioPharma Debt            
Debt Disclosure [Line Items]            
Amount received at the closing of the agreement $ 100,000,000.0          
Maximum repayment of future revenue and receivables $ 150,000,000.0          
Royalty-Bearing Debt            
Debt Disclosure [Line Items]            
Gain (loss) on change in fair value of derivative liabilities       $ 0 0  
Long-term debt from royalty-bearing instrument, carrying amount net of unamortized discount     $ 9,400,000 9,400,000   $ 49,700,000
Royalty-Bearing Debt | Cash            
Debt Disclosure [Line Items]            
Interest expense, contractual coupon interest       1,500,000 3,400,000  
Royalty-Bearing Debt | Non Cash            
Debt Disclosure [Line Items]            
Interest expense, non-cash       $ 600,000 $ 1,300,000